Lilly says Mounjaro and Zepbound sales more than doubled as stock rallies
Neutral
0.0
Late last year, Lilly was the first pharmaceutical stock to reach a $1 trillion valuation.
Pulse AI Analysis
Pulse analysis not available yet. Click "Get Pulse" above.
This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.
